TrialJournal for immunotherapy of cancer2020

Durvalumab and tremelimumab with or without stereotactic body radiation therapy in relapsed small cell lung cancer: a randomized phase II study.

Suchita Pakkala et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.